Insmed, Inc. (INSM) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for INSM. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 653 institutions reported holding INSM, with 223.1 million shares worth $23.8 billion in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| Vanguard | 22,242,827 | $2.4B | INCREASED |
| FMR | 16,143,583 | $1.7B | INCREASED |
| BlackRock | 15,807,984 | $1.7B | DECREASED |
| JPMorgan Chase | 10,428,170 | $1.1B | DECREASED |
| Baker Bros. Advisors | 8,796,111 | $938M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Paul Hudson (Director) | AWARD | 6,139 | 2026-10-19 | |
| Utpal Koppikar (Director) | AWARD | 6,139 | 2026-10-19 | |
| David R Brennan (Director) | SELL | 25,000 | $3M | 2026-09-09 |
| Melvin Sharoky MD (Director) | SELL | 5,000 | $638K | 2026-08-17 |
| Roger Adsett (Chief Operating Officer) | EXERCISE | 80,970 | $2M | 2026-08-10 |
Full institutional holdings, insider history, and congressional trades for Insmed, Inc. on SentiSense.